Close Menu

Diagnostics Reimbursement

News and trends on diagnostics testing, insurance coverage, and reimbursement.

A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors.

NantHealth CEO Patrick Soon-Shiong said that the company is seeking a fast-track FDA clearance predicated on Memorial Sloan Kettering's 468-gene panel.

A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors. 

The Medicare contractor said in its draft guidance it would provide limited coverage for the cell-free DNA assay, which should be used as a supplemental test.

Medicare contractor Palmetto is proposing to expand coverage to ensure that more patients have access to genomic profiling when tissue-based testing is not possible.